Japan's biggest drugmaker said it will incur restructuring costs of about 140 billion yen ($899 million) this fiscal year as ...

A promising human clinical trial on four patients may pave the way for a new treatment of glioblastoma, an aggressive form of ...

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

The Department of Health in Davao Region (DOH-11) is urging more parents of nine to 14-year-old girls to avail of the free ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an ...

Lavalle further explained, “In situ vaccines are a form of cancer immunotherapy which aim to transition the tumor itself into ...

Nurse Sandra Miceli, from Webster, New York, was fined $55,000 after allegedly falsifying vaccine records for more than 100 ...

A new vaccine designed to treat pancreatic cancer prevented the disease from returning in 50% of patients who received it, scientists reported today. Pancreatic cancer is notoriously hard to detect ...

A team has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

The VERSATILE-002 trial is evaluating Versamune ® HPV + KEYTRUDA ® (pembrolizumab) in patients with HPV16-positive HNSCC. Median overall survival (“mOS”) is 30 months (n=53) in first line recurrent ...

Moderna’s pioneering COVID shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its ...